within Pharmacolibrary.Drugs.D_Dermatologicals.D09A_MedicatedDressings.D09AA09_PovidoneIodine;

model PovidoneIodine
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C(
    weight = 70,
    F = 1,
    Cl = 0,
    adminDuration = 600,
    adminMass = 1 / 1000000,
    adminCount = 1,
    Vd = 0.001,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>PovidoneIodine</td></tr><tr><td>ATC code:</td><td>D09AA09</td></tr><td>route:</td><td>topical</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>1</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>1</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0</td><td></td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Povidone-iodine is a broad-spectrum antiseptic for topical application in the treatment and prevention of wound infection. It is used on skin, in wounds, and on mucous membranes for disinfection. It is widely approved and used today as an over-the-counter antiseptic in surgical scrubs, wound care, and infection control.</p><h4>Pharmacokinetics</h4><p>No pharmacokinetic parameters for povidone-iodine as a drug entity are reported in published literature for human subjects; systemic absorption is minimal when used topically. Most PK data available refer to iodine absorption from povidone-iodine, mainly in case reports or animal studies under specific conditions (e.g., burns, mucosal application), not suitable for PK modeling.</p><h4>References</h4><ol><li><p>Lin, YS, et al., &amp; Milgrom, P (2018). Pharmacokinetics of Iodine and Fluoride following Application of an Anticaries Varnish in Adults. <i>JDR clinical and translational research</i> 3(3) 238–245. DOI:<a href=\"https://doi.org/10.1177/2380084418771930\">10.1177/2380084418771930</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30938600/\">https://pubmed.ncbi.nlm.nih.gov/30938600</a></p></li><li><p>Below, H, et al., &amp; Rudolph, P (2006). Systemic iodine absorption after preoperative antisepsis using povidone-iodine in cataract surgery-- an open controlled study. <i>Dermatology (Basel, Switzerland)</i> 212 Suppl 1 41–46. DOI:<a href=\"https://doi.org/10.1159/000089198\">10.1159/000089198</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16490974/\">https://pubmed.ncbi.nlm.nih.gov/16490974</a></p></li><li><p>Tahirović, H, et al., &amp; Gnat, D (2009). Maternal and neonatal urinary iodine excretion and neonatal TSH in relation to use of antiseptic during caesarean section in an iodine sufficient area. <i>Journal of pediatric endocrinology &amp; metabolism : JPEM</i> 22(12) 1145–1149. DOI:<a href=\"https://doi.org/10.1515/jpem.2009.22.12.1145\">10.1515/jpem.2009.22.12.1145</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/20333874/\">https://pubmed.ncbi.nlm.nih.gov/20333874</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.D.D09AA09 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end PovidoneIodine;
